GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jolt Health Inc (STU:IY7) » Definitions » Cash-to-Debt

Jolt Health (STU:IY7) Cash-to-Debt : N/A (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Jolt Health Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Jolt Health's cash to debt ratio for the quarter that ended in Sep. 2024 was N/A.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Jolt Health's Cash-to-Debt or its related term are showing as below:

During the past 13 years, Jolt Health's highest Cash to Debt Ratio was No Debt. The lowest was 0.01. And the median was 0.83.

STU:IY7's Cash-to-Debt is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.93
* Ranked among companies with meaningful Cash-to-Debt only.

Jolt Health Cash-to-Debt Historical Data

The historical data trend for Jolt Health's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Jolt Health Cash-to-Debt Chart

Jolt Health Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Dec21 Dec22 Dec23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only No Debt No Debt 1.50 0.29 No Debt

Jolt Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only No Debt No Debt No Debt No Debt N/A

Competitive Comparison of Jolt Health's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Jolt Health's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jolt Health's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jolt Health's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Jolt Health's Cash-to-Debt falls into.



Jolt Health Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Jolt Health's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Jolt Health had no debt (1).

Jolt Health's Cash to Debt Ratio for the quarter that ended in Sep. 2024 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jolt Health  (STU:IY7) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Jolt Health Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Jolt Health's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Jolt Health Business Description

Traded in Other Exchanges
Address
355 Burrard Street, Suite 1780, Marine Building, Vancouver, BC, CAN, V6C 2G8
Jolt Health Inc is a licensee of certain technologies relating to certain controlled substances and pharmaceutical-grade therapeutics. The company is investigating business opportunities in other industries however has not reached a definitive decision to pursue alternative lines of business.

Jolt Health Headlines

No Headlines